15 DigitalHealth.London Accelerator SMEs and alumni have been included in the top 50 most innovative MedTech and HealthTech companies by BusinessCloud. MedTech companies include: Huma, Patchwork, Concentric, Vinehealth, Mendelian and HealthTech companies include: Feedback Medical, AccuRx, Dr Julian, Visionable, Feebris, Birdie, MedShr, MeeToo and Signum.
The annual ranking seeks to highlight the UK’s most innovative start-ups, scale-ups and established companies creating original technology for use within a healthcare setting.
The final ranking was agreed upon by an independent judging panel and a public vote on the shortlist which attracted around 1,300 votes.
Dr Dafydd Loughran, CEO, Concentric Health said: “We are delighted to be recognised by BusinessCloud as a key innovator within the health technology arena. We are hopeful that this will further strengthen Concentric’s positioning as a market leader in digital consent. Being part of the DigitalHealth.London Accelerator programme has given us access to valuable information and connections that are helping us grow and improve our offering to the NHS.”
Elina Naydenova, CEO and Co-founder, Feebris said: “Our mission is to accelerate treatment access by bringing AI-powered diagnosis to every home around the globe. Innovation and technology are central to this mission, so we’re proud to have been recognised by Business Cloud’s readers and independent judges as one of the UK’s 50 most innovative health technology creators. Together with patients and clinicians, we’re using machine-learning to cut diagnosis times and avoidable hospitalisations and to help health and care workers work smarter together. Thanks to all who voted, and please join us on our journey by following @Feebris.”
Nick Mayhew, Chief Marketing and Sales Officer, Feedback Medical Ltd said: “Through working with clinical professionals, Feedback Medical is focused on driving better outcomes for clinicians and patients and we are pleased that our efforts have been recognised by BusinessCloud. Our flagship clinical communications platform, Bleepa has going from strength to strength and is gaining significant traction in the NHS and the on-going support of the accelerator programme is of great value.”
Rudy Benfredj, Co-Founder and CEO, Mendelian said: “We are thrilled to have secured sixth place in the MedTech50. It’s a great recognition of our team’s hard work and also underlines the significant beneficial impact that early disease detection can bring to patients and healthcare providers. At Mendelian our team of clinicians and engineers are incredibly passionate about driving innovation in healthcare and enabling doctors to diagnose rare diseases and help patients earlier. The DigitalHealth.London Accelerator has been hugely beneficial in helping introduce Mendelian to key stakeholders within the NHS and helping to shape our offering to serve the needs of the NHS”
For more information, visit:
The DigitalHealth.London Accelerator is a collaborative programme funded by London’s three Academic Health Science Networks – UCL Partners, Imperial College Health Partners, and the Health Innovation Network, MedCity, CW+ and receives match funding from the European Regional Development Fund.